OpenVSafe by OpenVAERS
Search V-safe

6N5-21834-73857

4 vaccinations 14 coded responses 51 check-ins 13 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
921 / CA
Registered
2021-04-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
GNH-17453-89123 Child or adolescent in my care · Female · 2021-11-11

Timeline

  1. 2021-04-14
    Registered in v-safe
  2. 2021-04-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-14
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Myalgia, Sinus headache — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Headache = sinuses; muscle aches/soreness from exercising
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Decreased appetite, Throat irritation — Feeling: Fair · Fever · Fatigue or tiredness
    Free text: Throat irritation, thirstier than normal, decreased appetite
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Diarrhea
    Adult check-in
  7. 2021-04-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-23
    Survey response — day 7, dose 1
    MedDRA: Fatigue, Sinus headache — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sinus headache due to weather, fatigue due to allergy medication
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-28
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-05
    Dose 2 — Pfizer-BioNTech
  12. 2021-05-05
    Survey response — day 0, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Site: Pain
    Free text: increase in general inflammation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches
    Adult check-in
  14. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  15. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  17. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthma, Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Congestion, asthma
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-12
    Survey response — day 7, dose 2
    MedDRA: Discharge, Nasal congestion, Oropharyngeal pain — Feeling: Poor · Headache, Fatigue or tiredness
    Free text: sore throat, nasal congestion, drainage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-19
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Headache, Oropharyngeal pain, Paranasal sinus discomfort, Sinus congestion, Upper-airway cough syndrome, Viral infection — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Viral infection including sore throat, sinus pressure, nasal and sinus congestion, headache, fatigue and post-nasal drainage ongoing 1 week.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-26
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-06-02
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-06-09
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-16
    Survey response — day 42, dose 2
    MedDRA: Headache, Oropharyngeal pain, Sinus congestion — Feeling: Fair
    Free text: Sinus congestion, headache and intermittent mild sore throat.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-08-04
    Survey response — 3 months, dose 2
    MedDRA: Discomfort, Disturbance in attention, Headache, Hypoaesthesia, Loss of proprioception, Nausea, Night sweats, Photosensitivity reaction, Speech disorder, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Facial numbing/heaviness, visual disturbance, focal issues, speech issues, hand/arm numbing, loss of proprioception, nausea, headache, photosensitivity, night sweats
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-04
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-10-15
  28. 2021-10-20
  29. 2021-11-03
    Survey response — 6 months, dose 2
    MedDRA: Cognitive disorder, Headache, Hypoaesthesia, Migraine, Nausea, Photosensitivity reaction, Pre-existing disease, Speech disorder, Vision blurred — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: migraine - newly diagnosed due to marked worsening of pre-existing symptoms and addition of new symptoms (nausea, headache, visual blurring, cognitive and speech issues, facial numbing, photosensitivity)
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-11-10
    Dose 3 — Pfizer-BioNTech
  31. 2021-11-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  32. 2021-11-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  33. 2021-11-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  34. 2021-11-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  35. 2021-11-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  36. 2021-11-19
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  37. 2021-11-26
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-12-01
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  39. 2021-12-10
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  40. 2021-12-15
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  41. 2021-12-22
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  42. 2022-02-09
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-05-11
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  44. 2022-09-07
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  45. 2022-09-07
    Health check-in — day 0, dose 4
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  46. 2022-09-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  47. 2022-09-09
    Survey response — days 1–6 daily, dose 4
    MedDRA: Arthralgia, Lymph node pain — Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Entire shoulder/armpit (lymph nodes) involvement for pain, but limited to just that region
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-09-10
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  49. 2022-09-11
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  50. 2022-09-12
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  51. 2022-09-13
    Survey response — days 1–6 daily, dose 4
    MedDRA: Abdominal discomfort, Defaecation urgency, Faeces soft, Frequent bowel movements — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea
    Free text: Repeated soft stool in larger than normal quantity with urgency and GI upset, but not loose/watery to the point of diarrhea.
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-09-14
    Health check-in — day 7, dose 4
    Feeling: Fair · Site: Redness · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  53. 2022-09-21
    Survey response — day 14, dose 4
    MedDRA: Abdominal discomfort, Diarrhoea, Dyspepsia, Nausea, Regurgitation, Self-medication — Feeling: Good · Be unable to do your normal daily activities
    Free text: 3 days of nausea & GI distress including dyspepsia & diarrhea. Mostly able to function with medication (immodium), lost one morning to nausea. No complete emesis, though some repeated regurgitation when swallowing medication. Duration: 09/15-18.
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-09-28
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  55. 2022-10-05
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  56. 2022-10-12
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  57. 2022-10-19
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  58. 2022-12-07
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  59. 2023-03-08
    Survey response — 6 months, dose 4
    MedDRA: Hypoaesthesia, Intervertebral disc degeneration, Joint dislocation, Joint injury, Ligament injury, Office visit, Physiotherapy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  60. 2023-03-08
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  61. 2023-03-09
  62. 2023-03-09
  63. 2023-03-10
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  64. 2023-03-10
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-14Pfizer-BioNTech
22021-05-05Pfizer-BioNTech
32021-11-10Pfizer-BioNTech No
42022-09-07Pfizer-BioNTech Flu

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-15

Systemic reaction (other): Headache = sinuses; muscle aches/soreness from exercising

2021-04-16

Systemic reaction (other): Throat irritation, thirstier than normal, decreased appetite

Release 7 — day 7, dose 1

2021-04-23

Systemic reaction (other): Sinus headache due to weather, fatigue due to allergy medication

Release 8 — day 0, dose 2

2021-05-05

Systemic reaction (other): increase in general inflammation

Release 8 — days 1–6 daily, dose 2

2021-05-11

Systemic reaction (other): Congestion, asthma

Release 8 — day 7, dose 2

2021-05-12

Systemic reaction (other): sore throat, nasal congestion, drainage

Release 8 — day 14, dose 2

2021-05-19

Symptoms: Viral infection including sore throat, sinus pressure, nasal and sinus congestion, headache, fatigue and post-nasal drainage ongoing 1 week.

Release 9 — day 42, dose 2

2021-06-16

Symptoms: Sinus congestion, headache and intermittent mild sore throat.

Release 9 — 3 months, dose 2

2021-08-04

Symptoms: Facial numbing/heaviness, visual disturbance, focal issues, speech issues, hand/arm numbing, loss of proprioception, nausea, headache, photosensitivity, night sweats

Release 10 — 6 months, dose 2

2021-11-03

Symptoms: migraine - newly diagnosed due to marked worsening of pre-existing symptoms and addition of new symptoms (nausea, headache, visual blurring, cognitive and speech issues, facial numbing, photosensitivity)

Release 12 — days 1–6 daily, dose 4

2022-09-09

Systemic reaction (other): Entire shoulder/armpit (lymph nodes) involvement for pain, but limited to just that region

2022-09-13

Systemic reaction (other): Repeated soft stool in larger than normal quantity with urgency and GI upset, but not loose/watery to the point of diarrhea.

Release 12 — day 14, dose 4

2022-09-21

Symptoms: 3 days of nausea & GI distress including dyspepsia & diarrhea. Mostly able to function with medication (immodium), lost one morning to nausea. No complete emesis, though some repeated regurgitation when swallowing medication. Duration: 09/15-18.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOPhysiotherapy · · ✓
SDAbdominal discomfort · · ✓
SDCognitive disorder · · ✓
SDDiarrhoea · · ✓
SDDiscomfort ✓ · ✓
SDDisturbance in attention ✓ · ✓
SDDyspepsia · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypoaesthesia ✓ · ✓
SDIntervertebral disc degeneration · · ✓
SDJoint dislocation · · ✓
SDJoint injury · · ✓
SDLigament injury · · ✓
SDLoss of proprioception ✓ · ✓
SDMigraine · · ✓
SDNausea ✓ · ✓
SDNight sweats ✓ · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDParanasal sinus discomfort ✓ ✓ ✓
SDPhotosensitivity reaction ✓ · ✓
SDPre-existing disease · · ✓
SDRegurgitation · · ✓
SDSelf-medication · · ✓
SDSinus congestion ✓ ✓ ✓
SDSpeech disorder ✓ · ✓
SDUpper-airway cough syndrome ✓ ✓ ✓
SDViral infection ✓ ✓ ✓
SDVision blurred · · ✓
SDVisual impairment ✓ · ✓
SROAbdominal discomfort · · ✓
SROArthralgia · · ✓
SROAsthma ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODefaecation urgency · · ✓
SRODischarge ✓ ✓ ✓
SROFaeces soft · · ✓
SROFatigue ✓ ✓ ✓
SROFrequent bowel movements · · ✓
SROLymph node pain · · ✓
SROMyalgia ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SROSinus headache ✓ ✓ ✓
SROThroat irritation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release